Single Domain Antibody Platforms Industry 2025–2032: Market Outlook, Trends, and Key Players Including Merck, Ablynx, and Novartis
The global single domain antibody (sdAb) platforms market is witnessing robust momentum, driven by their expanding role in modern therapeutic and diagnostic development. According to industry estimates, the market is projected to reach a value of US$ 35.8 million in 2025 , advancing at a strong pace to US$ 67.2 million by 2032 , reflecting a compound annual growth rate (CAGR) of 9.7% during the forecast period of 2025–2032. Single domain antibodies, also known as nanobodies, have gained prominence for their unique properties, including small molecular size, high stability, and enhanced tissue penetration capabilities. These attributes make them particularly suitable for applications in oncology, immunology, infectious disease management, and diagnostics. The growing demand for targeted biologics, increased investment in precision medicine, and the expanding pipeline of antibody-based therapeutics are collectively driving significant market expansion. More...